Filing Details

Accession Number:
0000899243-22-035944
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-15 20:02:54
Reporting Period:
2022-11-11
Accepted Time:
2022-11-15 20:02:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759425 Mirum Pharmaceuticals Inc. MIRM Pharmaceutical Preparations (2834) 831281555
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780235 Niall O'donnell C/O Rivervest Venture Partners
101 S. Hanley Road Suite 1850
St.louis MO 63105
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-11-11 174,121 $19.99 1,746,997 No 4 S Indirect By RiverVest Venture Fund IV, L.P.
Common Stock Disposition 2022-11-14 32,109 $19.60 1,714,888 No 4 S Indirect By RiverVest Venture Fund IV, L.P.
Common Stock Disposition 2022-11-15 93,770 $19.69 1,621,118 No 4 S Indirect By RiverVest Venture Fund IV, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By RiverVest Venture Fund IV, L.P.
No 4 S Indirect By RiverVest Venture Fund IV, L.P.
No 4 S Indirect By RiverVest Venture Fund IV, L.P.
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.95 to $20.28, inclusive. The reporting persons undertake to provide Mirum Pharmaceuticals, Inc., any security holder of Mirum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3) and (4) to this Form 4.
  2. RiverVest Venture Partners IV, L.P. is the general partner of RiverVest Venture Fund IV, L.P. The Reporting Person is a manager of RiverVest Venture Partners IV, LLC, the sole general partner of RiverVest Venture Partners IV, L.P., and as a result may be deemed to share dispositive voting and investment power with respect to the shares held by RiverVest Venture Partners IV, L.P. The Reporting Person disclaims beneficial ownership of all shares held by RiverVest Venture Partners IV, L.P. except to the extent of his pecuniary interests therein.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.105 to $20.43, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $20.32, inclusive.